Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 6, 2011, Pages 748-754

  Kuc, S ^a,b   Wortelboer, E J ^b   Koster, M P H ^a,b   De Valk, H W ^b,c   Schielen, P C J I ^a   Visser, G H A ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Fetal macrosomia; first trimester; pregestational diabetes mellitus; serum markers

Indexed keywords

ADAM 12 PROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; HEMOGLOBIN A1C; PLACENTA PROTEIN 13; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROSOMIA; MAJOR CLINICAL STUDY; MALE; MATERNAL DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCHAL TRANSLUCENCY MEASUREMENT; PLACENTA DEVELOPMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCTION; SCREENING;

ADAM PROTEINS; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FETAL MACROSOMIA; GALECTINS; HUMANS; MEMBRANE PROTEINS; PLACENTATION; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; YOUNG ADULT;

EID: 79954479326     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.02904.x     Document Type: Article

References (33)

1. Persson M, Norman M, Hanson U,. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 2009; 32: 2005-9.
2. Evers IM, de Valk HW, Visser GHA,. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004; 328: 915.
3. Balsells M, Garcia-Patterson A, Gich I, Corcoy R,. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 2009; 94: 4284-91.
4. Allen VM, Armson BA, Wilson RD, Allen VM, Blight C, Gagnon A, et al., Society of Obstetricians and Gynecologists. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can 2007; 29: 927-44.
5. From the Centers for Disease Control. Perinatal mortality and congenital malformations in infants born to women with insulin-dependent diabetes mellitus-United States, Canada, and Europe, 1940-1988. JAMA 1990; 264:437, 441
6. Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GHA,. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 2002; 45: 1484-9.
7. Penney GC, Mair G, Pearson DW,. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG 2003; 110: 315-8. (Pubitemid 36298919)
8. Ehrenberg HM, Mercer BM, Catalano PM,. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191: 964-8. (Pubitemid 39298142)
9. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P,. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005; 28: 323-8. (Pubitemid 40170934)
10. Confidential Enquiry into Maternal. Child Health: Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002-03, England, Wales and Northern Ire-land. London: CEMACH, 2005.
11. Rijpert M, Evers IM, de Vroede MA, de Valk HW, Heijnen CJ, Visser GHA,. Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: Nationwide follow-up study in the Netherlands. Diabetes Care 2009; 32: 2099-104.
12. Higgins M, Mc Auliffe F,. A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev 2010; 6: 116-25.
13. Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al., First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007; 197: 35 e31-e37.
14. Cowans NJ, Spencer K,. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007; 27: 264-71. (Pubitemid 46450586)
15. Muetze S, Kapagerof A, Vlachopoulos L, Eggermann T, Kaufmann P, Zerres K, et al., Mutation analysis of the growth factor genes PlGF, Flt1, IGF-I, and IGF-IR in intrauterine growth restriction with abnormal placental blood flow. J Matern Fetal Neonatal Med 2010; 23: 142-7.
16. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, et al., Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004; 191: 1452-8. (Pubitemid 39421613)
17. Tul N, Pusenjak S, Osredkar J, Spencer K, Novak-Antolic Z,. Prediciting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A. Prenat Diagn 2003; 23: 990-6. (Pubitemid 38004790)
18. Poon LC, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH,. First-trimester prediction of macrosomia. Fetal Diagn Ther 2010, Aug 27 [Epub ahead of print].
19. Visser GHA, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM,. New Dutch reference curves for birthweight by gestational age. Early Hum Dev 2009; 85: 737-44.
20. Cuckle HS, Arbuzova S,. Multimarker serum screening for chromosomal abnormalities. Baltimore: Johns Hopkins University Press, 2004: 795-835.
21. Spencer K, Cicero S, Atzei A, Otigbah C, Nicolaides KH,. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2005; 25: 927-9. (Pubitemid 41494989)
22. Johnstone FD, Mao JH, Steel JM, Prescott RJ, Hume R,. Factors affecting fetal weight distribution in women with type I diabetes. BJOG 2000; 107: 1001-6. (Pubitemid 30495456)
23. Byun D, Mohan S, Yoo M, Sexton C, Baylink DJ, Qin X,. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab 2001; 86: 847-54. (Pubitemid 32207505)
24. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM,. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 1998; 273: 157-66. (Pubitemid 28042189)
25. Kumar A, Mohan S, Newton J, Rehage M, Tran K, Baylink DJ, et al., Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. J Biol Chem 2005; 280: 37782-9. (Pubitemid 41642388)
26. Loechel FJ, Fox W, Murphy G, Albrechtsen R, Wewer UM,. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000; 278: 511-5.
27. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV,. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 1984; 33: 1175-9. (Pubitemid 15176851)
28. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA,. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995; 80: 2282-8.
29. Bereket A, Lang CH, Wilson TA,. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res 1999; 31: 172-81. (Pubitemid 29169493)
30. Garay-Sevilla ME, Nava LE, Malacara JM, Wrobel K, Perez U,. Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 2000; 16: 106-13. (Pubitemid 30219046)
31. Knip M, Tapanainen P, Pekonen F, Blum WF,. Insulin-like growth factor binding proteins in prepubertal children with insulin-dependent diabetes mellitus. Eur J Endocrinol 1995; 133: 440-4.
32. Firth SM, Baxter RC,. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23: 824-54. (Pubitemid 35454590)
33. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, et al., IGF-I is required for normal embryonic growth in mice. Genes Dev 1993; 7: 2609-17. (Pubitemid 24021017)